Current Neuro-Oncology

Volume 24 Number 18
30 September 2022

Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 18, 30 September

*

Weller J, Katzendobler S, Blobner J, Thiele F, Becker H, Quach S, Egensperger R, Niyazi M, Suchorska B, Thon N, Weller M, Tonn JC.
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.
J Neurooncol. 2022 Sep 16∟. doi: 10.1007/s11060-022-04128-y∟. PMID: 36112301∟. Observational study. ˍ

Fan Y, Zhang X, Gao C, Jiang S, Wu H, Liu Z, Dou T.
Burden and trends of brain and central nervous system cancer from 1990 to 2019 at the global, regional, and country levels.
Arch Public Health. 2022 Sep 17;80(1):209∟. doi: 10.1186/s13690-022-00965-5∟. PMID: 36115969∟. Observational study. ˍ

Kashani E, Schnidrig D, Hashemi Gheinani A, Ninck MS, Zens P, Maragkou T, Baumgartner U, Schucht P, Rätsch G, Rubin MA, Berezowska S, Ng CKY, Vassella E; SOCIBP consortium.
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
Neuro Oncol. 2022 Sep 17, 2022:noac220∟. doi: 10.1093/neuonc/noac220∟. PMID: 36124685∟. Observational study. ˍ

Sherwood M, Climans S, Ramos R, Laperriere NJ, Gao AF, Millar BA, Shultz DB, Tsang DS, Mason WP.
Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival.
Neurooncol Pract. 2022 Sep 18, 2023;10(2):186-194∟. doi: 10.1093/nop/npac074∟. PMID: 36970168∟. Observational study˰ ˍ

Ge H, Di G, Yan Z, Liu D, Liu Y, Song K, Yang K, Hu X, Jiang Z, Hu X, Tian L, Xiao C, Zou Y, Liu H, Chen J.
Does epilepsy always indicate worse outcomes? A longitudinal follow-up analysis of 485 glioma patients.
World J Surg Oncol. 2022 Sep 19;20(1):297∟. doi: 10.1186/s12957-022-02772-2∟. PMID: 36117154∟. Observational study. ˍ

Tanedo J, Gajawelli N, Guo S, Baron Nelson M, Lepore N.
White matter tract changes in pediatric posterior fossa brain tumor survivors after surgery and chemotherapy.
Front Neuroimaging. 2022 Sep 20;1:845609∟. doi: 10.3389/fnimg.2022.845609∟. PMID: 37555139∟. Observational study. ˍ

He G, Chen Z, Zhuo S, Tang J, Hao W, Yang K, Yang C.
Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
Hum Cell. 2022 Sep 21;35(6):1976-1992∟. doi: 10.1007/s13577-022-00791-5∟. PMID: 36129672∟. Laboratory investigation˰ ˍ

*

Hendrikse LD, Haldipur P, Saulnier O, Millman J, Sjoboen AH, Erickson AW, Ong W, Gordon V, Coudière-Morrison L, Mercier AL, Shokouhian M, Suárez RA, Ly M, Borlase S, Scott DS, Vladoiu MC, Farooq H, Sirbu O, Nakashima T, Nambu S, Funakoshi Y, Bahcheli A, Diaz-Mejia JJ, Golser J, Bach K, Phuong-Bao T, Skowron P, Wang EY, Kumar SA, Balin P, Visvanathan A, Lee JJY, Ayoub R, Chen X, Chen X, Mungall KL, Luu B, Bérubé P, Wang YC, Pfister SM, Kim SK, Delattre O, Bourdeaut F, Doz F, Masliah-Planchon J, Grajkowska WA, Loukides J, Dirks P, Fèvre-Montange M, Jouvet A, French PJ, Kros JM, Zitterbart K, Bailey SD, Eberhart CG, Rao AAN, Giannini C, Olson JM, Garami M, Hauser P, Phillips JJ, Ra YS, de Torres C, Mora J, Li KKW, Ng HK, Poon WS, Pollack IF, López-Aguilar E, Gillespie GY, Van Meter TE, Shofuda T, Vibhakar R, Thompson RC, Cooper MK, Rubin JB, Kumabe T, Jung S, Lach B, Lolascon A, Ferrucci V, de Antonellis P, Zollo M, Cinalli G, Robinson S, Stearns DS, Van Meir EG, Porrati P, Finocchiaro G, Massimino M, Carlotti CG, Faria CC, Roussel MF, Boop F, Chan JA, Aldinger KA, Razavi F, Silvestri E, McLendon RE, Thompson EM, Ansari M, Garre ML, Chico F, Eguía P, Pérezpeña M, Morrissy AS, Cavalli FMG, Wu X, Daniels C, Rich JN, Jones SJM, Moore RA, Marra MA, Huang X, Reimand J, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Pugh TJ, Garzia L, Kleinman CL, Stein LD, Jabado N, Malkin D, Ayrault O, Golden JA, Ellison DW, Doble B, Ramaswamy V, Werbowetski-Ogilvie TE, Suzuki H, Millen KJ, Taylor MD.
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature. 2022 Sep 21;609(7929):1021-1028∟. doi: 10.1038/s41586-022-05215-w∟. PMID: 36131014∟. Laboratory investigation˰ ˍ

Hunt CM, Thomas V, Alexander J.
Glioblastoma Multiforme Survivor With Radiation-Induced Consequences: A Case Report.
Cureus. 2022 Sep 21;14(9):e29397∟. doi: 10.7759/cureus.29397∟. PMID: 36304371∟. Case report. ˍ

Phoenix TN.
The origins of medulloblastoma tumours in humans.
Nature. 2022 Sep 21;609(7929):901-903∟. doi: 10.1038/d41586-022-02951-x∟. PMID: 36131054∟. Comment˰ ˍ
Refers to: Hendrikse LD, et al., Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature. 2022 Sep 21;609(7929):1021-1028∟. doi: 10.1038/s41586-022-05215-w∟. PMID: 36131014∟. Laboratory investigation˰ ˍ
Refers to: Smith KS, et al., Unified rhombic lip origins of group 3 and group 4 medulloblastoma.
Nature. 2022 Sep 21;609(7929):1012-1020∟. doi: 10.1038/s41586-022-05208-9∟. PMID: 36131015∟. Laboratory investigation˰ ˍ

*

Smith KS, Bihannic L, Gudenas BL, Haldipur P, Tao R, Gao Q, Li Y, Aldinger KA, Iskusnykh IY, Chizhikov VV, Scoggins M, Zhang S, Edwards A, Deng M, Glass IA, Overman LM, Millman J, Sjoboen AH, Hadley J, Golser J, Mankad K, Sheppard H, Onar-Thomas A, Gajjar A, Robinson GW, Hovestadt V, Orr BA, Patay Z, Millen KJ, Northcott PA.
Unified rhombic lip origins of group 3 and group 4 medulloblastoma.
Nature. 2022 Sep 21;609(7929):1012-1020∟. doi: 10.1038/s41586-022-05208-9∟. PMID: 36131015∟. Laboratory investigation˰ ˍ

*

Ciammella P, Cozzi S, Botti A, Giaccherini L, Sghedoni R, Orlandi M, Napoli M, Pascarella R, Pisanello A, Russo M, Cavallieri F, Ruggieri MP, Cavuto S, Savoldi L, Iotti C, Iori M.
Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL).
Cancers (Basel). 2022 Sep 22;14(19):4604∟. doi: 10.3390/cancers14194604∟. PMID: 36230525∟. Interventional study. ˍ

van der Boog ATJ, Rados M, Akkermans A, Dankbaar JW, Kizilates U, Snijders TJ, Hendrikse J, Verhoeff JJC, Hoff RG, Robe PA.
Occurrence, Risk Factors, and Consequences of Postoperative Ischemia After Glioma Resection: A Retrospective Study.
Neurosurgery. 2022 Sep 22∟. doi: 10.1227/neu.0000000000002149∟. PMID: 36135366∟. Observational study˰ ˍ

Ge H, Yan Z, Liu D, Qi W, Chen S, Yang K, Liu H, Zou Y, Hu X, Liu Y, Chen J.
Synergetic reorganization of the contralateral structure and function in patients with unilateral frontal glioma.
Front Neurosci. 2022 Sep 23;16:1016693∟. doi: 10.3389/fnins.2022.1016693∟. PMID: 36213734∟. Observational study. ˍ

*

Metts JL, Trucco M, Weiser DA, Thompson P, Sandler E, Smith T, Crimella J, Sansil S, Thapa R, Fridley BL, Llosa N, Badgett T, Gorlick R, Reed D, Gill J.
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.
Cancer Med. 2022 Sep 23∟. doi: 10.1002/cam4.5297∟. PMID: 36151773∟. Interventional study. ˍ

Schiff JP, Lee Y, Wang Y, Perkins SM, Kessel SK, Fitzgerald TJ, Larrier NA, Michalski JM.
An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
Adv Radiat Oncol. 2022 Sep 23, 2023;8(1):101083∟. doi: 10.1016/j.adro.2022.101083∟. PMID: 36483060∟. Observational study. ˍ

Chen J, Chen S, Li B, Zhou S, Lin H.
A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Cancer Med. 2022 Sep 26∟. doi: 10.1002/cam4.5247∟. PMID: 36161280∟. Laboratory investigation. ˍ

Rahman M, Eisenschenk S, Melnick K, Wang Y, Heaton S, Ghiaseddin A, Hodik M, McGrew N, Smith J, Murad G, Roper S, Cibula J.
Duration of Prophylactic Levetiracetam After Surgery for Brain Tumor: A Prospective Randomized Trial.
Neurosurgery. 2022 Sep 26∟. doi: 10.1227/neu.0000000000002164∟. PMID: 36156532∟. Interventional study˰ ˍ

Altieri R, Broggi G, Certo F, Pacella D, Cammarata G, Maione M, Garozzo M, Barbagallo D, Purrello M, Caltabiano R, Magro G, Barbagallo G.
Anatomical distribution of cancer stem cells between enhancing nodule and FLAIR hyperintensity in supratentorial glioblastoma: time to recalibrate the surgical target?
Neurosurg Rev. 2022 Sep 28∟. doi: 10.1007/s10143-022-01863-8∟. PMID: 36171505∟. Laboratory investigation˰ ˍ

Chiesa S, Mangraviti A, Martini M, Cenci T, Mazzarella C, Gaudino S, Bracci S, Martino A, Della Pepa GM, Offi M, Gessi M, Russo R, Martucci M, Beghella Bartoli F, Larocca LM, Lauretti L, Olivi A, Pallini R, Balducci M, D'Alessandris QG.
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma.
Sci Rep. 2022 Sep 28;12(1):16265∟. doi: 10.1038/s41598-022-20417-y∟. PMID: 36171338∟. Laboratory investigation. ˍ

Long C, Yuan L, Wei W, Li J.
Overcoming chemoresistance in glioblastoma by fluvastatin via prenylation-dependent inhibition of Ras signaling.
Hum Exp Toxicol. 2022 Sep 28;41:9603271221125934∟. doi: 10.1177/09603271221125934∟. PMID: 36171180∟. Laboratory investigation. ˍ

Liouta E, Kalyvas AV, Komaitis S, Drosos E, Koutsarnakis C, García-Gómez JM, Juan-Albarracín J, Katsaros V, Kalamatianos T, Argyrakos T, Stranjalis G.
Association between preoperative neurocognitive status and IDH1 mutation status in high-grade gliomas.
Neurooncol Pract. 2022 Sep 30, 2023;10(2):132-139∟. doi: 10.1093/nop/npac077∟. PMID: 36970174∟. Observational study. ˍ

Zhao K, Liu R, Li Z, Liu M, Zhao Y, Xue Z, Wu W, Sun G, Xu B.
The imaging features and prognosis of gliomas involving the subventricular zone: An MRI study.
Clin Neurol Neurosurg. 2022 Sep 30;222:107465∟. doi: 10.1016/j.clineuro.2022.107465∟. PMID: 36201899∟. Observational study˰ ˍ